The importance of IL-1β in CFS was proved using a neutralizing antibody against IL-1β (48) or IL-1 receptor antagonist (51) injected into the lateral ventricle of rats. Here, IL1B is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.